WINSTON-SALEM, N.C. – August 7, 2024 – According to the American Cancer Society, there are an estimated 650,000 adolescent and young...
Immunotherapy pioneer Dr. Antoni Ribas, professor of medicine at the David Geffen School of Medicine at UCLA and director of...
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
Cancer doesn’t grow in a vacuum—each tumor grows in a particular microenvironment within the body and spreads through a tangled...
A transformative study has provided a profound understanding of glioblastoma's molecular subtypes, revealing the nuances of cellular heterogeneity and the...
New research from a team of genome scientists and DNA damage response experts breaks new ground in understanding the function...
FOR IMMEDIATE RELEASECredit: Elizabeth Cook FOR IMMEDIATE RELEASE A new drug for treatment of a type of brain cancer, called...
Boston – Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas...
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents the cells from killing other...
*Note this is an early release from the Annual Meeting of the European Association of the Study of Diabetes (EASD...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2024 Scienmag - Science Magazine
© 2024 Scienmag - Science Magazine